{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:52:20Z","timestamp":1789051940682,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2017E280301"],"award-info":[{"award-number":["2017E280301"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We aimed to estimate the socioeconomic burden of pneumonia due to multidrug-resistant <jats:italic>Acinetobacter baumannii<\/jats:italic> (MRAB) and <jats:italic>Pseudomonas aeruginosa<\/jats:italic> (MRPA). We prospectively searched for MRAB and MRPA pneumonia cases and matched them with susceptible-organism pneumonia and non-infected patients from 10 hospitals. The matching criteria were: same principal diagnosis, same surgery or intervention during hospitalisation, age, sex, and admission date within 60\u00a0days. We calculated the economic burden by using the difference in hospital costs, the difference in caregiver costs, and the sum of productivity loss from an unexpected death. We identified 108 MRAB pneumonia [MRAB-P] and 28 MRPA pneumonia [MRPA-P] cases. The estimated number of annual MRAB-P and MRPA-P cases in South Korea were 1309\u20132483 and 339\u2013644, with 485\u2013920 and 133\u2013253 deaths, respectively. The annual socioeconomic burden of MRAB-P and MRPA-P in South Korea was $64,549,723\u2013122,533,585 and $15,241,883\u201328,994,008, respectively. The results revealed that MRAB-P and MRPA-P occurred in 1648\u20133127 patients, resulted in 618\u20131173 deaths, and caused a nationwide socioeconomic burden of $79,791,606\u2013151,527,593. Multidrug-resistant organisms (MDRO) impose a great clinical and economic burden at a national level. Therefore, controlling the spread of MDRO will be an effective measure to reduce this burden.<\/jats:p>","DOI":"10.1038\/s41598-022-18189-6","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T09:03:09Z","timestamp":1660726989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea"],"prefix":"10.1038","volume":"12","author":[{"given":"Chung-Jong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Ho","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam-Kyong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeonghoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younghee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Soon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hwan","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eu Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Mi","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je Eun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Gyung","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Hye","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Hwa","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Min","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyoeng Gyun","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Bin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Korea INfectious Diseases (KIND) Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Mi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook-In","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Su","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"18189_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/17476348.2019.1562339","volume":"13","author":"P Peyrani","year":"2019","unstructured":"Peyrani, P., Mandell, L., Torres, A. & Tillotson, G. S. The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance. Expert Rev. Respir. Med. 13, 139\u2013152 (2019).","journal-title":"Expert Rev. Respir. Med."},{"key":"18189_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.prrv.2005.03.002","volume":"6","author":"V Singh","year":"2005","unstructured":"Singh, V. The burden of pneumonia in children: An Asian perspective. Paediatr. Respir. Rev. 6, 88\u201393 (2005).","journal-title":"Paediatr. Respir. Rev."},{"key":"18189_CR3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.vaccine.2011.11.103","volume":"30","author":"A Li","year":"2012","unstructured":"Li, A., Newall, A. T., Britt, H. & Macintyre, C. R. The cost and disease burden of pneumonia in general practice in Australia. Vaccine 30, 830\u2013831 (2012).","journal-title":"Vaccine"},{"key":"18189_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3947\/ic.2018.50.4.287","volume":"50","author":"JY Heo","year":"2018","unstructured":"Heo, J. Y. & Song, J. Y. Disease burden and etiologic distribution of community-acquired pneumonia in adults: Evolving epidemiology in the era of Pneumococcal Conjugate Vaccines. Infect. Chemother. 50, 287\u2013300 (2018).","journal-title":"Infect. Chemother."},{"key":"18189_CR5","doi-asserted-by":"publisher","first-page":"e8429","DOI":"10.1097\/MD.0000000000008429","volume":"96","author":"MJ Choi","year":"2017","unstructured":"Choi, M. J. et al. Disease burden of hospitalized community-acquired pneumonia in South Korea: Analysis based on age and underlying medical conditions. Medicine (Baltimore) 96, e8429 (2017).","journal-title":"Medicine (Baltimore)"},{"key":"18189_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3904\/kjim.2014.29.6.764","volume":"29","author":"JY Lee","year":"2014","unstructured":"Lee, J. Y., Yoo, C. G., Kim, H. J., Jung, K. S. & Yoo, K. H. Disease burden of pneumonia in Korean adults aged over 50 years stratified by age and underlying diseases. Korean J. Intern. Med. 29, 764\u2013773 (2014).","journal-title":"Korean J. Intern. Med."},{"key":"18189_CR7","doi-asserted-by":"publisher","first-page":"S570","DOI":"10.1093\/infdis\/jiz053","volume":"222","author":"T Shi","year":"2020","unstructured":"Shi, T. et al. Global and regional burden of hospital admissions for pneumonia in older adults: A systematic review and meta-analysis. J. Infect. Dis. 222, S570\u2013S576 (2020).","journal-title":"J. Infect. Dis."},{"issue":"Suppl 5","key":"18189_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/1469-0691.12461","volume":"20","author":"JJ Drijkoningen","year":"2014","unstructured":"Drijkoningen, J. J. & Rohde, G. G. Pneumococcal infection in adults: Burden of disease. Clin. Microbiol. Infect. 20(Suppl 5), 45\u201351 (2014).","journal-title":"Clin. Microbiol. Infect."},{"key":"18189_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijid.2014.05.030","volume":"29","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Disease burden of intensive care unit-acquired pneumonia in China: A systematic review and meta-analysis. Int. J. Infect. Dis. 29, 84\u201390 (2014).","journal-title":"Int. J. Infect. Dis."},{"issue":"Suppl 1","key":"18189_CR10","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1086\/653053","volume":"51","author":"RN Jones","year":"2010","unstructured":"Jones, R. N. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin. Infect. Dis. 51(Suppl 1), S81\u2013S87 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"18189_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/MCC.0000000000000756","volume":"26","author":"D Koulenti","year":"2020","unstructured":"Koulenti, D., Zhang, Y. & Fragkou, P. C. Nosocomial pneumonia diagnosis revisited. Curr. Opin. Crit. Care 26, 442\u2013449 (2020).","journal-title":"Curr. Opin. Crit. Care"},{"key":"18189_CR12","doi-asserted-by":"publisher","first-page":"106278","DOI":"10.1016\/j.ijantimicag.2021.106278","volume":"57","author":"MG Johnson","year":"2021","unstructured":"Johnson, M. G. et al. Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase-3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP). Int. J. Antimicrob. Agents 57, 106278 (2021).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"18189_CR13","first-page":"25","volume":"10","author":"MA El-Mokhtar","year":"2021","unstructured":"El-Mokhtar, M. A., Daef, E., Mohamed Hussein, A. A. R., Hashem, M. K. & Hassan, H. M. Emergence of nosocomial pneumonia caused by colistin-resistant Escherichia coli in patients admitted to chest Intensive Care Unit. Antibiotics (Basel) 10, 25 (2021).","journal-title":"Antibiotics (Basel)"},{"key":"18189_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1128\/AAC.02461-20","volume":"65","author":"M Castanheira","year":"2021","unstructured":"Castanheira, M. et al. Molecular characterization of baseline Enterobacterales and Pseudomonas aeruginosa isolates from a Phase 3 nosocomial pneumonia (ASPECT-NP) clinical trial. Antimicrob. Agents Chemother. 65, 25 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"18189_CR15","first-page":"25","volume":"9","author":"E Xu","year":"2021","unstructured":"Xu, E., P\u00e9rez-Torres, D., Fragkou, P. C., Zahar, J. R. & Koulenti, D. Nosocomial pneumonia in the era of multidrug-resistance: Updates in diagnosis and management. Microorganisms 9, 25 (2021).","journal-title":"Microorganisms"},{"key":"18189_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1201\/9781003069263-6","volume":"20","author":"J Chastre","year":"2020","unstructured":"Chastre, J., Trouillet, J.-L., Vuagnat, A. & Joly-Guillou, M.-L. Nosocomial pneumonia caused by Acinetobacter spp.. Acinetobacter 20, 117\u2013132 (2020).","journal-title":"Acinetobacter"},{"key":"18189_CR17","doi-asserted-by":"publisher","first-page":"e25440","DOI":"10.1097\/MD.0000000000025440","volume":"100","author":"X Zhong","year":"2021","unstructured":"Zhong, X., Wang, D. L. & Xiao, L. H. Research on the economic loss of hospital-acquired pneumonia caused by Klebsiella pneumonia base on propensity score matching. Medicine (Baltim.) 100, e25440 (2021).","journal-title":"Medicine (Baltim.)"},{"key":"18189_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/antibiotics9010025","volume":"9","author":"X Zhen","year":"2020","unstructured":"Zhen, X., St\u00e5lsby Lundborg, C., Sun, X., Gu, S. & Dong, H. Clinical and economic burden of carbapenem-resistant infection or colonization caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: A multicenter study in China. Antibiotics (Basel) 9, 25 (2020).","journal-title":"Antibiotics (Basel)"},{"key":"18189_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jinf.2019.12.021","volume":"80","author":"I L\u00f3pez-Montesinos","year":"2020","unstructured":"L\u00f3pez-Montesinos, I. et al. Clinical and economic burden of community-onset multidrug-resistant infections requiring hospitalization. J. Infect. 80, 271\u2013278 (2020).","journal-title":"J. Infect."},{"key":"18189_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/1756-0500-7-232","volume":"7","author":"M Behnia","year":"2014","unstructured":"Behnia, M., Logan, S. C., Fallen, L. & Catalano, P. Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: A retrospective review and analysis. BMC Res. Notes 7, 232 (2014).","journal-title":"BMC Res. Notes"},{"key":"18189_CR21","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1186\/s12879-019-4660-5","volume":"19","author":"K Kaier","year":"2019","unstructured":"Kaier, K., Heister, T., G\u00f6tting, T., Wolkewitz, M. & Mutters, N. T. Measuring the in-hospital costs of Pseudomonas aeruginosa pneumonia: Methodology and results from a German teaching hospital. BMC Infect. Dis. 19, 1028 (2019).","journal-title":"BMC Infect. Dis."},{"key":"18189_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1586\/erp.10.49","volume":"10","author":"EB Hirsch","year":"2010","unstructured":"Hirsch, E. B. & Tam, V. H. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert Rev. Pharmacoecon. Outcomes Res. 10, 441\u2013451 (2010).","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"18189_CR23","doi-asserted-by":"publisher","first-page":"R112","DOI":"10.1186\/cc10136","volume":"15","author":"C Kaminski","year":"2011","unstructured":"Kaminski, C. et al. Impact of ureido\/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa. Crit. Care 15, R112 (2011).","journal-title":"Crit. Care"},{"key":"18189_CR24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/cid\/cis552","volume":"55","author":"MJ Neidell","year":"2012","unstructured":"Neidell, M. J. et al. Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms. Clin. Infect. Dis. 55, 807\u2013815 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"18189_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10096-012-1758-8","volume":"32","author":"C Pe\u00f1a","year":"2013","unstructured":"Pe\u00f1a, C. et al. Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: Predictors of early and crude mortality. Eur. J. Clin. Microbiol. Infect. Dis. 32, 413\u2013420 (2013).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"18189_CR26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.20344\/amp.11607","volume":"32","author":"RD Costa","year":"2019","unstructured":"Costa, R. D., Baptista, J. P., Freitas, R. & Martins, P. J. Hospital-acquired pneumonia in a multipurpose Intensive Care Unit: One-year prospective study. Acta Med. Port. 32, 746\u2013753 (2019).","journal-title":"Acta Med. Port."},{"key":"18189_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jinf.2019.09.012","volume":"79","author":"S Mohd Sazlly Lim","year":"2019","unstructured":"Mohd Sazlly Lim, S., Zainal Abidin, A., Liew, S. M., Roberts, J. A. & Sime, F. B. The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis. J. Infect. 79, 593\u2013600 (2019).","journal-title":"J. Infect."},{"key":"18189_CR28","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.ajic.2019.02.030","volume":"47","author":"JB Denis","year":"2019","unstructured":"Denis, J. B. et al. Multidrug-resistant Pseudomonas aeruginosa and mortality in mechanically ventilated ICU patients. Am. J. Infect. Control 47, 1059\u20131064 (2019).","journal-title":"Am. J. Infect. Control"},{"key":"18189_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jiac.2018.09.011","volume":"25","author":"SH Choi","year":"2019","unstructured":"Choi, S. H., Cho, E. B., Chung, J. W. & Lee, M. K. Changes in the early mortality of adult patients with carbapenem-resistant Acinetobacter baumannii bacteremia during 11 years at an academic medical center. J. Infect. Chemother. 25, 6\u201311 (2019).","journal-title":"J. Infect. Chemother."},{"key":"18189_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ajic.2014.07.014","volume":"43","author":"AW Dick","year":"2015","unstructured":"Dick, A. W. et al. A decade of investment in infection prevention: A cost-effectiveness analysis. Am. J. Infect. Control 43, 4\u20139 (2015).","journal-title":"Am. J. Infect. Control"},{"key":"18189_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13756-015-0045-8","volume":"4","author":"A Vasudevan","year":"2015","unstructured":"Vasudevan, A., Memon, B. I., Mukhopadhyay, A., Li, J. & Tambyah, P. A. The costs of nosocomial resistant gram negative intensive care unit infections among patients with the systemic inflammatory response syndrome\u2014a propensity matched case control study. Antimicrob. Resist. Infect. Control 4, 3 (2015).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"18189_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2807\/1560-7917.ES.2016.21.33.30319","volume":"21","author":"AJ Stewardson","year":"2016","unstructured":"Stewardson, A. J. et al. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: A multicentre retrospective cohort study. Euro Surveill. 21, 25 (2016).","journal-title":"Euro Surveill."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18189-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18189-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18189-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T07:15:39Z","timestamp":1669360539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18189-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18189"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18189-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"assertion":[{"value":"3 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13934"}}